In particular, high titers of anti-GAD65 antibodies (> 10,000 IU/mL) are a specific marker for SPS but may also be associated with other neurological disorders such as cerebellar ataxia, epilepsy, and limbic encephalitis (1, 18). The gene discussed is GAD2; the disease is aceruloplasminemia.